Skip to main content
. Author manuscript; available in PMC: 2016 Jan 26.
Published in final edited form as: J Pathol. 2011 Oct 18;226(1):40–49. doi: 10.1002/path.2996

Figure 4.

Figure 4

Increased eRMS incidence and decreased age of onset in cardiotoxin-treated p53-deficient mice. Muscle regeneration was induced by treatment of wild-type (Trp53+/+) and p53-deficient (Trp53−/−) mice with cardiotoxin (Ctx). Ctx-treated Trp53−/− mice showed robust induction of embryonal rhabdomyosarcoma (eRMS) by 5 months of age. n = 50 Trp53+/+ (wild-type), 12 Ctx-Trp53+/+ (cardiotoxin-injected), 22 Trp53−/−, 10 Ctx-Trp53−/− (cardiotoxin-injected).